Effect of docetaxel combined with cisplatin and 5-fluorouracil for advanced gastric cancer
10.3760/cma.j.issn.1008-6706.2010.10.014
- VernacularTitle:多西他赛联合顺铂和氟尿嘧啶治疗进展期胃癌的疗效评价
- Author:
Qiuqin ZHANG
;
Weiqiang ZHU
;
Sanrong XU
- Publication Type:Journal Article
- Keywords:
Stomach neoplasms;
Docetaxel;
Cisplatin;
Fluorouracil;
Antineoplastic combined chemotherapy protocols
- From:
Chinese Journal of Primary Medicine and Pharmacy
2010;17(10):1322-1323
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the efficacy and toxicity of docetaxel combined with Cisplatin(DDP) and 5-fluorouracil(5-Fu) in the treatment of advanced gastric cancer. Methods 35 patients with advanced gastric cancer,which were confirmed by pathological diagnosis,were treated with docetaxel + DDP +5-Fu regimen:docetaxel 70 mg/m2 iv infusion for 4 hours on day 1, DDP 20 mg/m2 iv infusion on day 1 to 5,5-Fu 750 mg/m2 iv infusion for 6 hours on day 1 to 5 every 3 ～ 4weeks. Patients responsing to the chemotherapy finished at least 4 ～ 6 cycles or proceeded the therapy until progression of the disease (PD). Results 32 cases (91.4% ) were available for response evaluation with CR0;PR 15;SD7;PD 10. The rate of total remission( CR + PR) was 46.9% (15/32) ,and rates of CR and SD were 0 and 21.9% respectively. Leucopenia was seen in 40% patients,in which 13.6% cases were in grade III -IV. One patient had fever with neutropenia and improved after active treatment. There was no systemic infection or therapy-related death in all patients. Conclusion Docetaxel + DDP +5-Fu regimen has an assured response for advanced gastric cancer with tolerable toxicity and could be an effective candidate in clinical treatment.
